Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
Swedish Medical Center
ClinicalTrials.gov Identifier:
NCT00430261
First received: January 30, 2007
Last updated: October 5, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)